Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02453620 |
|---|---|
| Brief Title: | Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer |
| First Submitted : | May 21, 2015 |
| First Submitted that Met QC Criteria : | May 21, 2015 |
| First Posted : | May 25, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 19, 2021 |
| Last Update Posted : | January 20, 2021 |